-
公开(公告)号:EP3226819A1
公开(公告)日:2017-10-11
申请号:EP15823030.0
申请日:2015-11-25
申请人: New Phase Ltd.
发明人: HOF, Raphael , KHANDADASH, Raz , FREMDER, Ella
CPC分类号: A61K41/0052 , A61F7/00 , A61K47/06 , A61K47/549 , A61K47/60 , A61K47/6929 , A61K47/6935 , A61N1/406
摘要: Apparatus and methods are described for use with a subject suffering from cancer. A nanoparticle (22) includes an inner core (30) that comprises a phase-change material that is configured to absorb latent heat of fusion by undergoing a phase change. An outer layer (32) disposed around the inner core includes a plurality of nano-spheres (34) of at least one metal, and a plurality of molecules (38) of a substance that binds preferentially with cancerous cells relative to non-cancerous cells. The nanoparticle has a volume of at least 65,000 nm3 and is elongatable into an ellipsoid, such that, when the nanoparticle is maximally elongated, each of the semi-axes defined by the ellipsoid is greater than 5 nm, and at least two of the semi axes of the ellipsoid are less than 30 nm. Other applications are also described.
摘要翻译: 描述了用于患有癌症的受试者的装置和方法。 纳米颗粒(22)包括内芯(30),所述内芯包含被配置为通过经历相变来吸收熔化潜热的相变材料。 围绕内核布置的外层(32)包括多个至少一种金属的纳米球(34)和多个分子(38),所述分子(38)相对于非癌细胞优先与癌细胞结合 。 纳米颗粒具有至少65,000nm 3的体积并且可伸长成椭圆体,使得当纳米颗粒被最大程度地拉长时,椭圆体所限定的每个半轴大于5nm,并且至少两个 椭圆体的半轴小于30nm。 其他应用也被描述。
-
公开(公告)号:EP3585432A1
公开(公告)日:2020-01-01
申请号:EP18714616.2
申请日:2018-02-20
申请人: New Phase Ltd.
发明人: HOF, Raphael
-
公开(公告)号:EP3226819B1
公开(公告)日:2018-10-24
申请号:EP15823030.0
申请日:2015-11-25
申请人: New Phase Ltd.
发明人: HOF, Raphael , KHANDADASH, Raz , FREMDER, Ella
CPC分类号: A61K41/0052 , A61F7/00 , A61K47/06 , A61K47/549 , A61K47/60 , A61K47/6929 , A61K47/6935 , A61N1/406
摘要: Apparatus and methods are described for use with a subject suffering from cancer. A nanoparticle (22) includes an inner core (30) that comprises a phase-change material that is configured to absorb latent heat of fusion by undergoing a phase change. An outer layer (32) disposed around the inner core includes a plurality of nano-spheres (34) of at least one metal, and a plurality of molecules (38) of a substance that binds preferentially with cancerous cells relative to non-cancerous cells. The nanoparticle has a volume of at least 65,000 nm3 and is elongatable into an ellipsoid, such that, when the nanoparticle is maximally elongated, each of the semi-axes defined by the ellipsoid is greater than 5 nm, and at least two of the semi axes of the ellipsoid are less than 30 nm. Other applications are also described.
-
-